Adam Kuspa
Directeur Technique/Scientifique/R&D chez Baylor College of Medicine
Profil
Adam Kuspa is currently the Director at Diversigen, Inc., FGH Biotech, Inc., and Vice President-Research at Baylor College of Medicine.
He holds a doctorate degree from Stanford University and an undergraduate degree from the University of California San Diego.
Postes actifs de Adam Kuspa
| Sociétés | Poste | Début |
|---|---|---|
Diversigen, Inc.
 Diversigen, Inc. Miscellaneous Commercial ServicesCommercial Services Diversigen, Inc. provides microbiome and metagenomics services. The firm also offers data analysis, focused on solutions to improve human and animal health, environmental conditions and agriculture production worldwide. It offers metagenomics, single organism genome, microbial RNA, and viral metagenomics sequencing services. The company was founded by Joseph F. Petrosino in 2013 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
| Baylor College of Medicine | Directeur Technique/Scientifique/R&D | - |
FGH Biotech, Inc.
 FGH Biotech, Inc. Pharmaceuticals: MajorHealth Technology FGH Biotech, Inc. is a drug discovery and development company that specializes in the development of drugs for the treatment of metabolic disorders. The firm's products are used in various treatment indications, such as obesity, non-alcoholic fatty liver disease, type II diabetes, lipid disorders, cardiovascular disease, and cancer therapy. The company was founded by Salih J. Wakil, Motonari Uesugi and Lutfi Abu-Elheiga in 2011 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
Formation de Adam Kuspa
| Stanford University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Diversigen, Inc.
Diversigen, Inc. Miscellaneous Commercial ServicesCommercial Services Diversigen, Inc. provides microbiome and metagenomics services. The firm also offers data analysis, focused on solutions to improve human and animal health, environmental conditions and agriculture production worldwide. It offers metagenomics, single organism genome, microbial RNA, and viral metagenomics sequencing services. The company was founded by Joseph F. Petrosino in 2013 and is headquartered in Houston, TX. | Commercial Services |
FGH Biotech, Inc.
FGH Biotech, Inc. Pharmaceuticals: MajorHealth Technology FGH Biotech, Inc. is a drug discovery and development company that specializes in the development of drugs for the treatment of metabolic disorders. The firm's products are used in various treatment indications, such as obesity, non-alcoholic fatty liver disease, type II diabetes, lipid disorders, cardiovascular disease, and cancer therapy. The company was founded by Salih J. Wakil, Motonari Uesugi and Lutfi Abu-Elheiga in 2011 and is headquartered in Houston, TX. | Health Technology |